Importantly, depletion of MYCN in MYCN-amplification NB induces the tumor cell apoptosis, differentiation and cell growth retardation, indicating that inhibiting MYCN by targeting its transcription and protein stability might be a therapeutic strategy for MYCN-amplification NB [6, 7]. Here, MYCN is linked to neuroblastoma.